retatrutide phase 2 trial type 2 diabetes results 2024 Lilly's triple agonist achieves 16.8% weight loss in 3 Retatrutide UK Guide: Key Facts

Never share injection devices with others

Participation in a clinical trial is the only legitimate route to accessing retatrutide at present, and eligibility criteria apply

Crucially, these peptides offer a conceptual alternative to appetite-centric approaches for metabolic disease

You may also qualify if you have a BMI of 27-30 and a condition like high blood pressure or high cholesterol

The retatrutide listing includes molecular formula and molecular weight fields for consistent documentation, along with a stated purity threshold aligned to LC MS measurement

Curr Diabetes Rev 14(3):273279 Mousavi A et al (2025) Safety, efficacy, and cardiovascular benefits of combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists in patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials